Orbital Rosai-Dorfman disease initially diagnosed as IgG4-related disease: a case report

[1]  F. Vega,et al.  Primary cutaneous Rosai-Dorfman disease; a case-based review of a diagnostically and therapeutically challenging rare variant. , 2019, Annals of diagnostic pathology.

[2]  S. Heegaard,et al.  Diagnosis of Orbital Mass Lesions Clinical, Radiological and Pathological Recommendations. , 2019, Survey of ophthalmology.

[3]  D. Salomão,et al.  Distinguishing IgG4-Related Ophthalmic Disease From Graves Orbitopathy. , 2019, Ophthalmic plastic and reconstructive surgery.

[4]  R. Verdijk,et al.  The treatment outcomes in IgG4‐related orbital disease: a systematic review of the literature , 2019, Acta ophthalmologica.

[5]  G. Tirelli,et al.  Head and neck immunoglobulin G4 related disease: systematic review , 2018, The Journal of Laryngology & Otology.

[6]  E. Jacobsen,et al.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. , 2018, Blood.

[7]  D. Rontogianni,et al.  Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report , 2018, Clinical Rheumatology.

[8]  Bernie Chang,et al.  How accurate is the clinical and radiological evaluation of orbital lesions in comparison to surgical orbital biopsy? , 2018, Eye.

[9]  S. Staibano,et al.  Inflammatory myofibroblastic tumor of the orbit: A clinico-pathological study of 25 cases , 2018, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[10]  R. Senetta,et al.  A 68‐Year‐Old Woman with A Left Orbital and Temporal Mass , 2018, Brain pathology.

[11]  Larissa A Habib,et al.  Spontaneous regression of inflammatory myofibroblastic tumor of the orbit: A case report and review of literature , 2017, Orbit.

[12]  V. Surabhi,et al.  Inflammatory Myofibroblastic Tumors: Current Update. , 2016, The Radiologic clinics of North America.

[13]  R. Verdijk,et al.  IgG4-related disease: a systematic review of this unrecognized disease in pediatrics , 2016, Pediatric Rheumatology.

[14]  T. Al-Khateeb.  Cutaneous Rosai-Dorfman Disease of the Face: A Comprehensive Literature Review and Case Report. , 2016, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[15]  J. Stone,et al.  International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease , 2015, Arthritis & rheumatology.

[16]  P. Satija,et al.  Immunoglobulin G4-related diseases in the head and neck: a systematic review , 2015, Journal of Otolaryngology - Head & Neck Surgery.

[17]  V. Deshpande.  IgG4 Related Disease of the Head and Neck , 2015, Head and Neck Pathology.

[18]  J. Stone,et al.  Rituximab for IgG4-related disease: a prospective, open-label trial , 2015, Annals of the rheumatic diseases.

[19]  V. Dutta,et al.  ALK negative inflammatory myofibroblastic tumor of the orbit: A masquerading entity , 2014, Indian journal of ophthalmology.

[20]  E. Jaffe,et al.  A subset of Rosai–Dorfman disease cases show increased IgG4‐positive plasma cells: another red herring or a true association with IgG4‐related disease? , 2014, Histopathology.

[21]  D. Weisenburger,et al.  Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases. , 2013, American journal of clinical pathology.

[22]  J. Vardiman,et al.  A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease. , 2013, American journal of clinical pathology.

[23]  C. V. van Hasselt,et al.  Rosai–dorfman disease: Presentation, diagnosis, and treatment , 2013, Head & neck.

[24]  D. Sahani,et al.  Consensus statement on the pathology of IgG4-related disease , 2012, Modern Pathology.

[25]  C. Edelsten,et al.  Inflammatory lesions of the orbit: a single paediatric rheumatology centre experience , 2011, Rheumatology.

[26]  B. Petersen,et al.  Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. , 2010, Gastroenterology.

[27]  T. Kamisawa,et al.  Autoimmune pancreatitis and IgG4-related sclerosing disease , 2010, Nature Reviews Gastroenterology &Hepatology.

[28]  Li‐yu Lee,et al.  IgG4‐positive plasma cells in cutaneous Rosai‐Dorfman disease: an additional immunohistochemical feature and possible relationship to IgG4‐related sclerosing disease , 2009, Journal of cutaneous pathology.

[29]  S. Honavar,et al.  Rosai dorfman disease of the orbit , 2008, Journal of hematology & oncology.

[30]  Y. Nakanuma,et al.  Th2 and regulatory immune reactions are increased in immunoglobin G4‐related sclerosing pancreatitis and cholangitis , 2007, Hepatology.

[31]  A. Vincent-Salomon,et al.  Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. , 2006, Blood.

[32]  J. Rootman,et al.  The Spectrum of Orbital Rosai-Dorfman Disease , 2006, Ophthalmic plastic and reconstructive surgery.

[33]  C. Shields,et al.  Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. , 2004, Ophthalmology.

[34]  F. Mandelli,et al.  Treatment of sinus histiocytosis with massive lymphadenopathy (rosai‐dorfman disease): Report of a case and literature review , 2002, American journal of hematology.

[35]  G. Harris,et al.  ORBITAL VASCULAR LESIONS , 2000 .

[36]  J. Rosai,et al.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. , 1990, Seminars in diagnostic pathology.

[37]  J. Rosai,et al.  The ophthalmologic manifestations of sinus histiocytosis with massive lymphadenopathy. , 1979, American journal of ophthalmology.

[38]  R. Jaffe,et al.  Pathology of Histiocytic Disorders and Neoplasms and Related Disorders , 2018 .

[39]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[40]  L. Bilaniuk,et al.  Orbital vascular lesions. Role of imaging. , 1999, Radiologic clinics of North America.